Attune Pharmaceuticals Overview

  • Year Founded
  • 2017

Year Founded

  • Status
  • Private

  • Latest Deal Type
  • Series B

  • Latest Deal Amount
  • $23.3M

  • Investors
  • 7

Attune Pharmaceuticals General Information

Description

Developer of orally administered small molecule therapeutics designed for the treatment of rare diseases. The company offers small molecule drug development and serine protease targeting approaches to create targeted therapies for rare and underserved diseases, enabling patients with rare disease conditions and healthcare providers to access treatments that improve disease management and clinical outcomes.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 250 West 55th Street
  • 34th Floor
  • New York, NY 10019
  • United States
+1 (229)
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Vertical(s)
Corporate Office
  • 250 West 55th Street
  • 34th Floor
  • New York, NY 10019
  • United States
+1 (229)

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Attune Pharmaceuticals Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Early Stage VC (Series B) 23-Jan-2019 $23.3M Completed Clinical Trials - Phase 1
1. Early Stage VC (Series A) Completed Startup
To view Attune Pharmaceuticals’s complete valuation and funding history, request access »

Attune Pharmaceuticals Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series B
Series A
To view Attune Pharmaceuticals’s complete cap table history, request access »

Attune Pharmaceuticals Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of orally administered small molecule therapeutics designed for the treatment of rare diseases. The company of
Drug Discovery
New York, NY

San Diego, CA
 

Balma, France
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Attune Pharmaceuticals Competitors (68)

One of Attune Pharmaceuticals’s 68 competitors is Klotho Therapeutics, a Formerly VC-backed company based in San Diego, CA.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Klotho Therapeutics Formerly VC-backed San Diego, CA
ABIONYX Pharma Formerly VC-backed Balma, France
Altimmune Formerly VC-backed Gaithersburg, MD
Cour Venture Capital-Backed Skokie, IL
Xenetic Biosciences Corporation Framingham, MA
You’re viewing 5 of 68 competitors. Get the full list »

Attune Pharmaceuticals Patents

Attune Pharmaceuticals Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
AU-2019227866-A1 Treatment of hereditary angioedema Inactive 28-Feb-2018
CA-3092538-A1 Treatment of hereditary angioedema Inactive 28-Feb-2018
EP-3758702-A1 Treatment of hereditary angioedema Inactive 28-Feb-2018
EP-3758702-A4 Treatment of hereditary angioedema Inactive 28-Feb-2018
US-20200405708-A1 Treatment of hereditary angioedema Inactive 28-Feb-2018 A61P7/10
To view Attune Pharmaceuticals’s complete patent history, request access »

Attune Pharmaceuticals Investors (7)

Investor Name Investor Type Holding Investor Since Participating Rounds
Boxer Capital Corporate Venture Capital Minority
LifeSci Venture Partners Corporate Venture Capital Minority
RA Capital Management Asset Manager Minority
RTW Investments Hedge Fund Minority
Tang Capital Management Venture Capital Minority
You’re viewing 5 of 7 investors. Get the full list »

Attune Pharmaceuticals FAQs

  • When was Attune Pharmaceuticals founded?

    Attune Pharmaceuticals was founded in 2017.

  • Where is Attune Pharmaceuticals headquartered?

    Attune Pharmaceuticals is headquartered in New York, NY.

  • What industry is Attune Pharmaceuticals in?

    Attune Pharmaceuticals’s primary industry is Drug Discovery.

  • Is Attune Pharmaceuticals a private or public company?

    Attune Pharmaceuticals is a Private company.

  • What is the current valuation of Attune Pharmaceuticals?

    The current valuation of Attune Pharmaceuticals is .

  • What is Attune Pharmaceuticals’s current revenue?

    The current revenue for Attune Pharmaceuticals is .

  • How much funding has Attune Pharmaceuticals raised over time?

    Attune Pharmaceuticals has raised $30.8M.

  • Who are Attune Pharmaceuticals’s investors?

    Boxer Capital, LifeSci Venture Partners, RA Capital Management, RTW Investments, and Tang Capital Management are 5 of 7 investors who have invested in Attune Pharmaceuticals.

  • Who are Attune Pharmaceuticals’s competitors?

    Klotho Therapeutics, ABIONYX Pharma, Altimmune, Cour, and Xenetic Biosciences are some of the 68 competitors of Attune Pharmaceuticals.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process